Xu-Monette et al. found that a high proportion of PD1+ CD8+ T cells and PD-L1+ T cells in the tumor microenvironment (TME) predicted poor survival in DLBCL [29]. This evidence concerns the gene CD274 and diffuse large B-cell lymphoma.